Case Studies > Choroidal Melanoma
COUCH Health partnered with a top 10 biopharma company that were initiating a phase 3 clinical study in choroidal melanoma.
The Sponsor wanted to gain patient insights to refine and tailor their patient-facing study materials to be more appropriate, accessible, and inclusive for individuals with choroidal melanoma.
COUCH Health gathered insights from interviews and focus groups with people affected by choroidal melanoma to inform the development of these patient-facing study materials.
Choroidal melanoma often leads to vision impairment and visual disturbances, which will consequently impact the daily lives and accessibility needs of individuals living with the condition.
Patient-facing study materials for clinical studies are often designed without considering the needs and lived experiences of people with the condition, and their perspectives from different backgrounds and diverse communities.
The materials are often:
COUCH Health proposed 3 strategies designed to gather feedback on the patient-facing study materials to ensure the upcoming phase 3 clinical study was accessible and inclusive of all people living with choroidal melanoma:
COUCH Health engaged with individuals with choroidal melanoma from the US and UK
Patients provided feedback on the patient-facing study materials focusing on:
Patient feedback on the materials revealed key themes:
COUCH Health revised the materials with the patient feedback in mind while also applying best practices for DE&I, including:
UK address
COUCH Health
5 Richmond Street
Manchester, M1 3HF
+44 (0) 161 300 0874
US address
1111B S Governors Ave
STE 21906,
Dover, DE 19904
+1 321 985 1511
hello@couchhealth.agency
Receive exclusive insights from our experts on important topics and news within the inclusive clinical research space.